Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P38
Within normal range
vs 3Y Ago
-1.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -6.90% |
| Q3 2025 | 3.99% |
| Q2 2025 | 21.96% |
| Q1 2025 | -12.16% |
| Q4 2024 | 9.15% |
| Q3 2024 | -3.91% |
| Q2 2024 | 3.06% |
| Q1 2024 | -17.44% |
| Q4 2023 | 7.74% |
| Q3 2023 | -16.75% |
| Q2 2023 | 18.84% |
| Q1 2023 | -47.39% |
| Q4 2022 | 3.97% |
| Q3 2022 | 15.33% |
| Q2 2022 | -17.47% |
| Q1 2022 | 18.02% |
| Q4 2021 | -77.95% |
| Q3 2021 | 13.05% |
| Q2 2021 | -42.90% |
| Q1 2021 | 48.66% |
| Q4 2020 | -96.98% |
| Q3 2020 | 11.69% |
| Q2 2020 | -5.77% |
| Q1 2020 | 0.33% |
| Q4 2019 | -21.62% |
| Q3 2019 | 17.38% |
| Q2 2019 | -21.55% |
| Q1 2019 | 5.95% |
| Q4 2018 | -5.76% |
| Q3 2018 | -81.44% |
| Q2 2018 | 58.54% |
| Q1 2018 | -50.09% |
| Q4 2017 | -34.97% |
| Q3 2017 | -6.53% |
| Q2 2017 | 11.34% |
| Q1 2017 | 8.66% |
| Q4 2016 | 18.25% |
| Q3 2016 | -60.20% |
| Q2 2016 | -216.62% |
| Q1 2016 | 46.04% |